Patents by Inventor Susan Kramer

Susan Kramer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRODRUG OF A PHENOLIC TRPV1 AGONIST FOR THE TREATMENT OF PAIN
    Publication number: 20240058316
    Abstract: Described herein is a prodrug of a transient receptor potential vanilloid 1 receptor (TRPV1) agonist for the treatment of pain.
    Type: Application
    Filed: December 13, 2021
    Publication date: February 22, 2024
    Inventors: Sam L. TEICHMAN, Susan KRAMER, John F. DONOVAN
  • Instillation administration of capsaicinoids for the treatment of pain
    Patent number: 8158682
    Abstract: This present invention relates to methods for treating or attenuating pain in a patient. Specifically, the invention provides a method for attenuating pain in proximity to the site of an open wound or surgical incision comprising instilling a pharmaceutical composition comprising a capsaicinoid into the wound or incision, allowing the pharmaceutical composition to dwell for a predetermined period of time, and aspirating the wound or incision to remove the pharmaceutical composition. The invention also provides a method for attenuating pain in proximity to a joint comprising intra-articularly injecting a pharmaceutical composition comprising a capsaicinoid into the joint, allowing the pharmaceutical composition to dwell for predetermined period of time, and aspirating the joint to remove the pharmaceutical composition. In certain embodiments of the invention, the capsaicinoid is capsaicin.
    Type: Grant
    Filed: September 14, 2009
    Date of Patent: April 17, 2012
    Assignee: Vallinex, Inc.
    Inventors: Lakshmi Sangameswaran, Susan Kramer
  • Instillation Administration of Capsaicinoids for the Treatment of Pain
    Publication number: 20100234470
    Abstract: This present invention relates to methods for treating or attenuating pain in a patient. Specifically, the invention provides a method for attenuating pain in proximity to the site of an open wound or surgical incision comprising instilling a pharmaceutical composition comprising a capsaicinoid into the wound or incision, allowing the pharmaceutical composition to dwell for a predetermined period of time, and aspirating the wound or incision to remove the pharmaceutical composition. The invention also provides a method for attenuating pain in proximity to a joint comprising intra-articularly injecting a pharmaceutical composition comprising a capsaicinoid into the joint, allowing the pharmaceutical composition to dwell for predetermined period of time, and aspirating the joint to remove the pharmaceutical composition. In certain embodiments of the invention, the capsaicinoid is capsaicin.
    Type: Application
    Filed: September 14, 2009
    Publication date: September 16, 2010
    Applicant: ANESIVA, INC.
    Inventors: Lakshmi Sangameswaran, Susan Kramer
  • Treatment of LFA-1 Associated Disorders with Increasing Doses of LFA-1 Antagonist
    Publication number: 20080050364
    Abstract: A method is provided for reducing the occurrence of fever, headache, nausea and/or vomiting associated with administration of a therapeutic compound to a mammal in need thereof, comprising administering to the mammal a first conditioning dose of a non-target cell depleting compound which binds to a cell surface receptor on a target mammalian cell; and administering a second therapeutic dose of the compound, wherein the second dose is higher than the first dose.
    Type: Application
    Filed: October 30, 2007
    Publication date: February 28, 2008
    Applicants: Genentech, Inc., Xoma Ltd.
    Inventors: Marvin Garovoy, Susan Kramer, Russell Dedrick, Karen Starko
  • Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
    Publication number: 20050169916
    Abstract: A method is provided for reducing the occurrence of fever, headache, nausea and/or vomiting associated with administration of a therapeutic compound to a mammal in need thereof, comprising administering to the mammal a first conditioning dose of a non-target cell depleting compound which binds to a cell surface receptor on a target mammalian cell; and administering a second therapeutic dose of the compound, wherein the second dose is higher than the first dose.
    Type: Application
    Filed: March 10, 2005
    Publication date: August 4, 2005
    Inventors: Marvin Garovoy, Susan Kramer, Russell Dedrick, Karen Starko